Trademark: 97489630
Status Date
Tuesday, May 21, 2024
Registration Number
7390296
Registration Date
Tuesday, May 21, 2024
Filing Date
Tuesday, July 5, 2022
Published for Opposition
Tuesday, March 5, 2024
5 Anti-cancer preparations; Anti-cancer preparations of chemical origin; Anti-cancer preparations from hormones and antagonists; Anti-cancer preparations of microbial origin; Anti-cancer preparations of plant origin; Compounds for treating cancer; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Medical preparations for the treatment of cancer; Chemical preparations for medical purposes for the treatment of cancer; Biochemical preparations for medical use for the treatment of cancer; Biological preparations for medical purposes for the treatment of cancer; Anti-cancer drugs; Antitumor drugs; Injectable pharmaceuticals for the treatment of cancer; Medicinal preparations and substances for the treatment of cancer; Medicines for human purposes for the treatment of cancer; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical compositions for the treatment of cancer; Pharmaceutical drugs for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for human use for the treatment of cancer; Pharmaceutical preparations for treating gastrointestinal disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceuticals for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for suppressing tumors; Compounds for treating resistant cancers; Pharmaceutical preparations and substances for the treatment of treatment-resistant cancers
1 Active chemical ingredients for use in the manufacture of anti-cancer drugs
42 Scientific research for medical purposes in the area of cancerous diseases; Medical research in the field of oncology
The mark consists of eight turquoise dots of varying sizes arranged in a non-specific, constellation-like pattern with two large dots on the top left and two large dots along the bottom center and bottom right connected by a turquoise line.
The color(s) turquoise is/are claimed as a feature of the mark.
Jul 8, 2022
New Application Entered
Jul 25, 2022
New Application Office Supplied Data Entered
Jul 26, 2022
Notice Of Design Search Code E-Mailed
Dec 26, 2022
Assigned To Examiner
Dec 26, 2022
Non-Final Action Written
Dec 26, 2022
Non-Final Action E-Mailed
Dec 26, 2022
Notification Of Non-Final Action E-Mailed
Mar 24, 2023
Application Extension To Response Period - Received
Mar 24, 2023
Application Extension Granted/Receipt Provided
Jun 26, 2023
Teas Response To Office Action Received
Nov 30, 2023
Assigned To Lie
Nov 30, 2023
Correspondence Received In Law Office
Nov 30, 2023
Teas/Email Correspondence Entered
Jan 16, 2024
Examiners Amendment -Written
Jan 16, 2024
Examiners Amendment E-Mailed
Jan 16, 2024
Notification Of Examiners Amendment E-Mailed
Jan 16, 2024
Examiner's Amendment Entered
Jan 16, 2024
Approved For Pub - Principal Register
Jan 19, 2024
On Hold - Electronic Record Review Required
Jan 31, 2024
Electronic Record Review Complete
Feb 14, 2024
Notification Of Notice Of Publication E-Mailed
Feb 14, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 5, 2024
Published For Opposition
Mar 5, 2024
Official Gazette Publication Confirmation E-Mailed
May 21, 2024
Registered-Principal Register
May 21, 2024
Notice Of Registration Confirmation Emailed
Trademark Alertz updated from USPTO on 2030-01-24
